Loading…
Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus
The roles of gut microbiota in the pathogenesis of SLE have been receiving much attention during recent years. However, it remains unknown how fecal microbiota transplantation (FMT) and microbial metabolites affect immune responses and lupus progression. We transferred fecal microbiota from MRL/lpr...
Saved in:
Published in: | Arthritis research & therapy 2023-03, Vol.25 (1), p.42-42, Article 42 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c564t-b882aaf25f95e4540f7b52f94e2ff009fd8353494aef41dd79ec596fcebf3b7d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c564t-b882aaf25f95e4540f7b52f94e2ff009fd8353494aef41dd79ec596fcebf3b7d3 |
container_end_page | 42 |
container_issue | 1 |
container_start_page | 42 |
container_title | Arthritis research & therapy |
container_volume | 25 |
creator | Yi, Xiaoqing Huang, Cancan Huang, Chuyi Zhao, Ming Lu, Qianjin |
description | The roles of gut microbiota in the pathogenesis of SLE have been receiving much attention during recent years. However, it remains unknown how fecal microbiota transplantation (FMT) and microbial metabolites affect immune responses and lupus progression.
We transferred fecal microbiota from MRL/lpr (Lpr) mice and MRL/Mpj (Mpj) mice or PBS to pristane-induced lupus mice and observed disease development. We also screened gut microbiota and metabolite spectrums of pristane-induced lupus mice with FMT via 16S rRNA sequencing, metagenomic sequencing, and metabolomics, followed by correlation analysis.
FMT from MRL/lpr mice promoted the pathogenesis of pristane-induced lupus and affected immune cell profiles in the intestine, particularly the plasma cells. The structure and composition of microbial communities in the gut of the FMT-Lpr mice were different from those of the FMT-Mpj mice and FMT-PBS mice. The abundances of specific microbes such as prevotella taxa were predominantly elevated in the gut microbiome of the FMT-Lpr mice, which were positively associated with functional pathways such as cyanoamino acid metabolism. Differential metabolites such as valine and L-isoleucine were identified with varied abundances among the three groups. The abundance alterations of the prevotella taxa may affect the phenotypic changes such as proteinuria levels in the pristane-induced lupus mice.
These findings further confirm that gut microbiota play an important role in the pathogenesis of lupus. Thus, altering the gut microbiome may provide a novel way to treat lupus. |
doi_str_mv | 10.1186/s13075-023-03022-w |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_56f56f5ae32c4fa18a6f689c7afa6105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A741673293</galeid><doaj_id>oai_doaj_org_article_56f56f5ae32c4fa18a6f689c7afa6105</doaj_id><sourcerecordid>A741673293</sourcerecordid><originalsourceid>FETCH-LOGICAL-c564t-b882aaf25f95e4540f7b52f94e2ff009fd8353494aef41dd79ec596fcebf3b7d3</originalsourceid><addsrcrecordid>eNptUk1v1DAQjRCIlsIf4IAiceGS1t8fJ1RVLa20CAnB2Zo44yWrbLzYSQv_Hu9uW7oI2ZJH4_eePTOvqt5SckqpUWeZcqJlQxhvCCeMNXfPqmMqtGkUV-z5k_ioepXzihSMZeJldcSVZVpbeVxdXqGHoV73PsW2jxPUIcV1_fnr4mzYpG0ea_wFHlMLE-Z6k_o8wYhNP3azx64e5s2cX1cvAgwZ39yfJ9X3q8tvF9fN4sunm4vzReOlElPTGsMAApPBShRSkKBbyYIVyEIgxIbOcMmFFYBB0K7TFr20KnhsA291x0-qm71uF2Hlyl_WkH67CL3bJWJaOkhT7wd0UoXtBuTMiwDUgArKWK8hgKJEFq2Pe63N3K6x8zhOCYYD0cObsf_hlvHWUUKosVwVhQ_3Cin-nDFPbt1nj8NQ-hPn7Jg2xhCqOC3Q9_9AV3FOY-nVDiWJYkb9RS2hVNCPIZaH_VbUnWtBlebM8oI6_Q-qrA7LuOKIoS_5AwLbE8qMc04YHoukxG2d5PZOcsVJbuckd1dI756255HyYB3-B49Fw1k</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2788506286</pqid></control><display><type>article</type><title>Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Yi, Xiaoqing ; Huang, Cancan ; Huang, Chuyi ; Zhao, Ming ; Lu, Qianjin</creator><creatorcontrib>Yi, Xiaoqing ; Huang, Cancan ; Huang, Chuyi ; Zhao, Ming ; Lu, Qianjin</creatorcontrib><description>The roles of gut microbiota in the pathogenesis of SLE have been receiving much attention during recent years. However, it remains unknown how fecal microbiota transplantation (FMT) and microbial metabolites affect immune responses and lupus progression.
We transferred fecal microbiota from MRL/lpr (Lpr) mice and MRL/Mpj (Mpj) mice or PBS to pristane-induced lupus mice and observed disease development. We also screened gut microbiota and metabolite spectrums of pristane-induced lupus mice with FMT via 16S rRNA sequencing, metagenomic sequencing, and metabolomics, followed by correlation analysis.
FMT from MRL/lpr mice promoted the pathogenesis of pristane-induced lupus and affected immune cell profiles in the intestine, particularly the plasma cells. The structure and composition of microbial communities in the gut of the FMT-Lpr mice were different from those of the FMT-Mpj mice and FMT-PBS mice. The abundances of specific microbes such as prevotella taxa were predominantly elevated in the gut microbiome of the FMT-Lpr mice, which were positively associated with functional pathways such as cyanoamino acid metabolism. Differential metabolites such as valine and L-isoleucine were identified with varied abundances among the three groups. The abundance alterations of the prevotella taxa may affect the phenotypic changes such as proteinuria levels in the pristane-induced lupus mice.
These findings further confirm that gut microbiota play an important role in the pathogenesis of lupus. Thus, altering the gut microbiome may provide a novel way to treat lupus.</description><identifier>ISSN: 1478-6362</identifier><identifier>ISSN: 1478-6354</identifier><identifier>EISSN: 1478-6362</identifier><identifier>DOI: 10.1186/s13075-023-03022-w</identifier><identifier>PMID: 36927795</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Animals ; Antibodies ; Arthritis ; Autoimmunity ; Complications and side effects ; Development and progression ; Feces ; Flow cytometry ; Genes ; Immunological research ; L-Isoleucine ; Lupus ; Lupus Erythematosus, Systemic - chemically induced ; Lymphatic system ; Medical research ; Metabolomics ; Metagenomic sequencing ; Mice ; Mice, Inbred MRL lpr ; Microbiota ; Pathogenesis ; Prevotella ; RNA, Ribosomal, 16S - genetics ; SLE ; Valine</subject><ispartof>Arthritis research & therapy, 2023-03, Vol.25 (1), p.42-42, Article 42</ispartof><rights>2023. The Author(s).</rights><rights>COPYRIGHT 2023 BioMed Central Ltd.</rights><rights>2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c564t-b882aaf25f95e4540f7b52f94e2ff009fd8353494aef41dd79ec596fcebf3b7d3</citedby><cites>FETCH-LOGICAL-c564t-b882aaf25f95e4540f7b52f94e2ff009fd8353494aef41dd79ec596fcebf3b7d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018936/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2788506286?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36927795$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yi, Xiaoqing</creatorcontrib><creatorcontrib>Huang, Cancan</creatorcontrib><creatorcontrib>Huang, Chuyi</creatorcontrib><creatorcontrib>Zhao, Ming</creatorcontrib><creatorcontrib>Lu, Qianjin</creatorcontrib><title>Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus</title><title>Arthritis research & therapy</title><addtitle>Arthritis Res Ther</addtitle><description>The roles of gut microbiota in the pathogenesis of SLE have been receiving much attention during recent years. However, it remains unknown how fecal microbiota transplantation (FMT) and microbial metabolites affect immune responses and lupus progression.
We transferred fecal microbiota from MRL/lpr (Lpr) mice and MRL/Mpj (Mpj) mice or PBS to pristane-induced lupus mice and observed disease development. We also screened gut microbiota and metabolite spectrums of pristane-induced lupus mice with FMT via 16S rRNA sequencing, metagenomic sequencing, and metabolomics, followed by correlation analysis.
FMT from MRL/lpr mice promoted the pathogenesis of pristane-induced lupus and affected immune cell profiles in the intestine, particularly the plasma cells. The structure and composition of microbial communities in the gut of the FMT-Lpr mice were different from those of the FMT-Mpj mice and FMT-PBS mice. The abundances of specific microbes such as prevotella taxa were predominantly elevated in the gut microbiome of the FMT-Lpr mice, which were positively associated with functional pathways such as cyanoamino acid metabolism. Differential metabolites such as valine and L-isoleucine were identified with varied abundances among the three groups. The abundance alterations of the prevotella taxa may affect the phenotypic changes such as proteinuria levels in the pristane-induced lupus mice.
These findings further confirm that gut microbiota play an important role in the pathogenesis of lupus. Thus, altering the gut microbiome may provide a novel way to treat lupus.</description><subject>Animals</subject><subject>Antibodies</subject><subject>Arthritis</subject><subject>Autoimmunity</subject><subject>Complications and side effects</subject><subject>Development and progression</subject><subject>Feces</subject><subject>Flow cytometry</subject><subject>Genes</subject><subject>Immunological research</subject><subject>L-Isoleucine</subject><subject>Lupus</subject><subject>Lupus Erythematosus, Systemic - chemically induced</subject><subject>Lymphatic system</subject><subject>Medical research</subject><subject>Metabolomics</subject><subject>Metagenomic sequencing</subject><subject>Mice</subject><subject>Mice, Inbred MRL lpr</subject><subject>Microbiota</subject><subject>Pathogenesis</subject><subject>Prevotella</subject><subject>RNA, Ribosomal, 16S - genetics</subject><subject>SLE</subject><subject>Valine</subject><issn>1478-6362</issn><issn>1478-6354</issn><issn>1478-6362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUk1v1DAQjRCIlsIf4IAiceGS1t8fJ1RVLa20CAnB2Zo44yWrbLzYSQv_Hu9uW7oI2ZJH4_eePTOvqt5SckqpUWeZcqJlQxhvCCeMNXfPqmMqtGkUV-z5k_ioepXzihSMZeJldcSVZVpbeVxdXqGHoV73PsW2jxPUIcV1_fnr4mzYpG0ea_wFHlMLE-Z6k_o8wYhNP3azx64e5s2cX1cvAgwZ39yfJ9X3q8tvF9fN4sunm4vzReOlElPTGsMAApPBShRSkKBbyYIVyEIgxIbOcMmFFYBB0K7TFr20KnhsA291x0-qm71uF2Hlyl_WkH67CL3bJWJaOkhT7wd0UoXtBuTMiwDUgArKWK8hgKJEFq2Pe63N3K6x8zhOCYYD0cObsf_hlvHWUUKosVwVhQ_3Cin-nDFPbt1nj8NQ-hPn7Jg2xhCqOC3Q9_9AV3FOY-nVDiWJYkb9RS2hVNCPIZaH_VbUnWtBlebM8oI6_Q-qrA7LuOKIoS_5AwLbE8qMc04YHoukxG2d5PZOcsVJbuckd1dI756255HyYB3-B49Fw1k</recordid><startdate>20230316</startdate><enddate>20230316</enddate><creator>Yi, Xiaoqing</creator><creator>Huang, Cancan</creator><creator>Huang, Chuyi</creator><creator>Zhao, Ming</creator><creator>Lu, Qianjin</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230316</creationdate><title>Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus</title><author>Yi, Xiaoqing ; Huang, Cancan ; Huang, Chuyi ; Zhao, Ming ; Lu, Qianjin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c564t-b882aaf25f95e4540f7b52f94e2ff009fd8353494aef41dd79ec596fcebf3b7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Antibodies</topic><topic>Arthritis</topic><topic>Autoimmunity</topic><topic>Complications and side effects</topic><topic>Development and progression</topic><topic>Feces</topic><topic>Flow cytometry</topic><topic>Genes</topic><topic>Immunological research</topic><topic>L-Isoleucine</topic><topic>Lupus</topic><topic>Lupus Erythematosus, Systemic - chemically induced</topic><topic>Lymphatic system</topic><topic>Medical research</topic><topic>Metabolomics</topic><topic>Metagenomic sequencing</topic><topic>Mice</topic><topic>Mice, Inbred MRL lpr</topic><topic>Microbiota</topic><topic>Pathogenesis</topic><topic>Prevotella</topic><topic>RNA, Ribosomal, 16S - genetics</topic><topic>SLE</topic><topic>Valine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yi, Xiaoqing</creatorcontrib><creatorcontrib>Huang, Cancan</creatorcontrib><creatorcontrib>Huang, Chuyi</creatorcontrib><creatorcontrib>Zhao, Ming</creatorcontrib><creatorcontrib>Lu, Qianjin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Arthritis research & therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yi, Xiaoqing</au><au>Huang, Cancan</au><au>Huang, Chuyi</au><au>Zhao, Ming</au><au>Lu, Qianjin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus</atitle><jtitle>Arthritis research & therapy</jtitle><addtitle>Arthritis Res Ther</addtitle><date>2023-03-16</date><risdate>2023</risdate><volume>25</volume><issue>1</issue><spage>42</spage><epage>42</epage><pages>42-42</pages><artnum>42</artnum><issn>1478-6362</issn><issn>1478-6354</issn><eissn>1478-6362</eissn><abstract>The roles of gut microbiota in the pathogenesis of SLE have been receiving much attention during recent years. However, it remains unknown how fecal microbiota transplantation (FMT) and microbial metabolites affect immune responses and lupus progression.
We transferred fecal microbiota from MRL/lpr (Lpr) mice and MRL/Mpj (Mpj) mice or PBS to pristane-induced lupus mice and observed disease development. We also screened gut microbiota and metabolite spectrums of pristane-induced lupus mice with FMT via 16S rRNA sequencing, metagenomic sequencing, and metabolomics, followed by correlation analysis.
FMT from MRL/lpr mice promoted the pathogenesis of pristane-induced lupus and affected immune cell profiles in the intestine, particularly the plasma cells. The structure and composition of microbial communities in the gut of the FMT-Lpr mice were different from those of the FMT-Mpj mice and FMT-PBS mice. The abundances of specific microbes such as prevotella taxa were predominantly elevated in the gut microbiome of the FMT-Lpr mice, which were positively associated with functional pathways such as cyanoamino acid metabolism. Differential metabolites such as valine and L-isoleucine were identified with varied abundances among the three groups. The abundance alterations of the prevotella taxa may affect the phenotypic changes such as proteinuria levels in the pristane-induced lupus mice.
These findings further confirm that gut microbiota play an important role in the pathogenesis of lupus. Thus, altering the gut microbiome may provide a novel way to treat lupus.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>36927795</pmid><doi>10.1186/s13075-023-03022-w</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1478-6362 |
ispartof | Arthritis research & therapy, 2023-03, Vol.25 (1), p.42-42, Article 42 |
issn | 1478-6362 1478-6354 1478-6362 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_56f56f5ae32c4fa18a6f689c7afa6105 |
source | Publicly Available Content (ProQuest); PubMed Central |
subjects | Animals Antibodies Arthritis Autoimmunity Complications and side effects Development and progression Feces Flow cytometry Genes Immunological research L-Isoleucine Lupus Lupus Erythematosus, Systemic - chemically induced Lymphatic system Medical research Metabolomics Metagenomic sequencing Mice Mice, Inbred MRL lpr Microbiota Pathogenesis Prevotella RNA, Ribosomal, 16S - genetics SLE Valine |
title | Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T04%3A39%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fecal%20microbiota%20from%20MRL/lpr%20mice%20exacerbates%20pristane-induced%20lupus&rft.jtitle=Arthritis%20research%20&%20therapy&rft.au=Yi,%20Xiaoqing&rft.date=2023-03-16&rft.volume=25&rft.issue=1&rft.spage=42&rft.epage=42&rft.pages=42-42&rft.artnum=42&rft.issn=1478-6362&rft.eissn=1478-6362&rft_id=info:doi/10.1186/s13075-023-03022-w&rft_dat=%3Cgale_doaj_%3EA741673293%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c564t-b882aaf25f95e4540f7b52f94e2ff009fd8353494aef41dd79ec596fcebf3b7d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2788506286&rft_id=info:pmid/36927795&rft_galeid=A741673293&rfr_iscdi=true |